Lindab earnings for the third quarter of 2026 showed a return to organic sales growth and a recovery in margins from the previous quarter, but profitability remained below year-earlier levels. Results released on October 23 put organic growth at 2% and the adjusted operating margin at 8.7%, as stronger Nordic demand and price increases helped offset weakness in Western Europe.
Key Takeaways
- Organic sales grew 2%, but disposals and acquisitions together offset that increase in reported revenue.
- The adjusted operating margin recovered from 6.6% in Q2 to 8.7%, below the 9.7% recorded a year earlier.
- Management is pursuing further price increases and fixed-cost reductions as Western European profitability remains weak.
Table of Contents
- Lindab earnings show recovery, not a full turnaround
- Nordic growth contrasts with Western European weakness
- Cash generation weakens as costs remain under review
- Acquisitions expand the ventilation offering
- Conclusion
Lindab earnings show recovery, not a full turnaround
Lindab’s third-quarter interim results show net sales of SEK 3.237 billion, broadly unchanged from SEK 3.253 billion a year earlier. The net effect of acquisitions and divestments reduced growth by two percentage points, while currencies had no effect.
Adjusted operating profit fell to SEK 283 million from SEK 315 million. The sequential margin improvement therefore marks progress from a weaker second quarter, rather than a return to last year’s profitability.
Price adjustments helped restore gross margins after transportation and input-material costs increased. Chief Executive Ola Ringdahl said further pricing action and a lower fixed-cost base are still needed to strengthen operating margins.
| Item | Details |
|---|---|
| Q3 net profit | SEK 187 million, versus SEK 400 million in Q3 2025. |
| Q3 diluted earnings per share | SEK 2.42, versus SEK 5.19 a year earlier. |
| January–September net sales | SEK 9.546 billion, down 2% year over year. |
| January–September adjusted operating margin | 7.2%, versus 8.5% a year earlier. |
Nordic growth contrasts with Western European weakness
Organic sales in the Nordic markets increased 5%. Ventilation Systems delivered 1% organic growth and a 9.9% adjusted operating margin, while Profile Systems grew 4% organically and posted a 6.2% margin, down from 7.0% a year earlier.
Profile Systems benefited from stronger sales to builders’ merchants and improving project activity. Sandwich-panel production capacity returned to its level before the factory relocation process, removing an operational constraint.
Germany remained weak in both sales and profitability. Ringdahl also identified lower profitability in the Netherlands and parts of France. Management is reviewing fixed costs and implementing efficiency measures, while seeking to preserve growth in stronger markets.
Cash generation weakens as costs remain under review
Operating cash flow fell to SEK 235 million from SEK 335 million a year earlier. Chief Financial Officer Lars Ynner attributed weak cash conversion to seasonal inventory and receivables movements, saying there had been no underlying change.
Ynner said the fourth quarter is normally the strongest period for cash flow. That is a seasonal observation, not a quantified forecast for the final quarter of 2026.
The longer-period figures also show pressure: January–September adjusted operating profit declined to SEK 689 million from SEK 824 million, while operating cash flow fell to SEK 555 million from SEK 826 million.
Acquisitions expand the ventilation offering
Lindab acquired Irish ventilation distributor CVS during the third quarter. It signed an agreement in September to buy Italian smoke-control specialist Aernova, completing that transaction on October 13, after the reporting period ended.
Management expects modest growth in 2027 in both the European ventilation market and the Scandinavian profile market. Ringdahl highlighted renovation, energy efficiency, fire protection, data centres and defence as opportunities, while warning that Germany’s weakness is expected to persist into 2027.
Conclusion
The next test for Lindab earnings is whether further pricing and cost measures can sustain the margin recovery while improving cash generation in the fourth quarter. Management’s modest 2027 market outlook remains an expectation, with Nordic improvement still contrasting with weakness in Germany.
Read More News
Disclaimer
This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.
